KREBS BIOCHEMICALS & INDUSTRIES
|
The Current P/S Ratio of KREBS BIOCHEMICALS & INDUSTRIES is 5.25.
Share Price | ₹105.3 | Jun 09,2025 |
Market Cap | ₹227.4 Cr | |
Sales-TTM | ₹43.3 Cr | TTM-Standalone Results |
Price/Sales | 5.25x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of KREBS BIOCHEMICALS & INDUSTRIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹227.4 Cr] as on Jun 09,2025
(/) Sales [ ₹43.3 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 5.25x ]
Thus, for KREBS BIOCHEMICALS & INDUSTRIES , the investors are currently willing to pay '5.25 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of KREBS BIOCHEMICALS & INDUSTRIES !
The chart below summarizes the trend in P/S Ratio of KREBS BIOCHEMICALS & INDUSTRIES over the last five years.
Historical PS (Price/Sales) ratio chart of KREBS BIOCHEMICALS & INDUSTRIES
PS Ratio Performance Analysis for KREBS BIOCHEMICALS & INDUSTRIES
- KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.56x.
- KREBS BIOCHEMICALS & INDUSTRIES 's operated at median p/e ratio of 3.25x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio peaked in Mar2022 at 5.18x.
- KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio hit its five-year low in Mar2023 of 2.33x.
How does KREBS BIOCHEMICALS & INDUSTRIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
KREBS BIOCHEMICALS & INDUSTRIES | 43.3 | 5.25 | 227.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.73 | 406,519.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 18.79 | 175,903.0 |
CIPLA LTD | 27,547.6 | 4.42 | 121,669.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.34 | 107,605.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.37 | 110,097.0 |
MANKIND PHARMA LTD | 12,279.3 | 7.92 | 97,239.7 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.21 | 97,951.9 |
LUPIN LTD | 22,707.9 | 4.01 | 91,051.4 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.13 | 67,457.2 |
ABBOTT INDIA LTD | 6,409.2 | 10.55 | 67,600.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KREBS BIOCHEMICALS & INDUSTRIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.13x |
Max industry PS | 18.79x |
Median industry PS | 5.25x |
Average industry PS | 7.07x |
You may also like the below Video Courses